O uso intraoperatório de mitomicina C em glaucomas refratários

Costa, Vital Paulino; Wilson, Richard P; Moster, Marlene R; Schmidt, Courtland M; Gandham, Sai; Smith, Maura.
Rev. bras. oftalmol ; 54(1): 7-13, jan. 1995. tab
Artículo en Portugués | LILACS | ID: lil-148552

Documentos relacionados

  1. National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK.
  2. Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up.
  3. Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial.
  4. The developments in amniotic membrane transplantation in glaucoma and vitreoretinal procedures.
  5. [Pharmacological modulation of wound healing in glaucoma surgery].
  6. Intraocular pressure spikes after gonioscopy-assisted transluminal trabeculotomy (GATT).
  7. Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
  8. Device-modified trabeculectomy for glaucoma.
  9. Efficacy of anti-vascular endothelial growth factor and mitomycin C on wound healing after trabeculectomy in glaucoma patients: A meta-analysis.
  10. Adjunctive modulation of wound healing during cataract surgery to promote survival of a previous trabeculectomy.